Why Providers Are Stalling When It Comes to Scaling AI

Without a clear picture of which solutions are working and which ones aren’t, it’s difficult for providers to scale AI across their enterprise. As hospitals transition their AI efforts from experimentation mode to the widespread adoption phase, experts agree that more rigorous, real-world evidence is needed. The post Why Providers Are Stalling When It Comes…

Read More

Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx

Amid the Trump administration’s focus on lowering prescription drug costs, including its new TrumpRx website, KFF’s Health Tracking Poll finds that most Americans (59%) are worried about affording prescription drugs and support more regulation of prescription drug pricing (72%). Looking ahead to the 2026 midterm elections, the Democratic party currently holds the advantage when it…

Read More